Wealth Enhancement Advisory Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$671K Sell
3,858
-2,288
-37% -$424K ﹤0.01% 2101
2025
Q4
$1.33M Buy
6,146
+229
+4% +$41.5K ﹤0.01% 1783
2025
Q3
$1.01M Buy
5,917
+918
+18% +$146K ﹤0.01% 1864
2025
Q2
$785K Sell
4,999
-724
-13% -$96.5K ﹤0.01% 1893
2025
Q1
$861K Sell
5,723
-247
-4% -$41.4K ﹤0.01% 1680
2024
Q4
$1.1M Buy
5,970
+187
+3% +$36K ﹤0.01% 1485
2024
Q3
$1.14M Sell
5,783
-331
-5% -$68.8K ﹤0.01% 1320
2024
Q2
$1.26M Buy
6,114
+1,535
+34% +$348K ﹤0.01% 1172
2024
Q1
$1.24M Sell
4,579
-37
-0.8% -$8.84K ﹤0.01% 1140
2023
Q4
$1.09M Buy
4,616
+63
+1% +$12.4K ﹤0.01% 1138
2023
Q3
$892K Buy
+4,553
New +$935K ﹤0.01% 1150
2021
Q4
Sell
-19,303
Closed -$8.3M 306
2021
Q3
$8.3M Buy
+19,303
New +$8.02M 0.12% 82

Other funds holding CRL